By Mill Chart
Last update: Feb 26, 2024
Unearth the potential of NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) as a dividend stock recommended by our stock screening tool. NYSE:NVO maintains a robust financial footing and delivers a sustainable dividend. We'll delve into the details below.
ChartMill assigns a Dividend Rating to every stock. This score ranges from 0 to 10 and evaluates the different dividend aspects, including the yield, the growth and sustainability. NYSE:NVO scores a 7 out of 10:
ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NYSE:NVO scores a 7 out of 10:
Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NYSE:NVO has achieved a 9:
Every day, new Best Dividend stocks can be found on ChartMill in our Best Dividend screener.
Our latest full fundamental report of NVO contains the most current fundamental analsysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
NOVO-NORDISK A/S-SPONS ADR
NYSE:NVO (4/19/2024, 7:07:23 PM)
Premarket: 122.9 +0.19 (+0.15%)122.71
-0.04 (-0.03%)
Creators say the rules are unfair and harmful to their businesses
These stocks probably won't be getting much cheaper.
Low risk and high-reward potential? These stocks could offer both.
Low risk and high-reward potential? These stocks could offer both.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks offer the possibility of groundbreaking medical advancements alo...
These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains.
Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors looking for a white-knuckle ride can easily find one by buying b...